Stocks and Investing Stocks and Investing
Wed, May 8, 2024

Danielle Antalffy Maintained (TMCI) at Strong Buy with Decreased Target to $16 on, May 8th, 2024


Published on 2024-10-28 11:08:27 - WOPRAI, Danielle Antalffy
  Print publication without navigation


Danielle Antalffy of UBS, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $17 to $16 on, May 8th, 2024.

Danielle, nor any peers, have made any analyst calls on TMCI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources